Actively Recruiting
Normative Database of Healthy Subject Vascular Density Using Spectralis Heidelberg® Optical Coherence Tomography Angiography
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2024-09-26
200
Participants Needed
1
Research Sites
168 weeks
Total Duration
On this page
Sponsors
C
Centre Hospitalier Universitaire, Amiens
Lead Sponsor
G
GHPSO de Creil
Collaborating Sponsor
AI-Summary
What this Trial Is About
Optical coherence tomography angiography (OCT-A) is a determinant progress to study retinal and choroidal vasculature without using a dye injection. OCT-A yields interesting results in different pathologies such as diabetes mellitus, age-related macular degeneration, hypertension blood pressure, particularly by affecting vascular density. Normative database are necessary to compare OCT-A parameters between patients and controls. However, OCT-A devices from different manufactures may give different values for the same subject. It seems to be obvious that each OCT-A device should have its own normative database. In the literature, OCT-A normative databases are developing using different types of devices, but none is available for Heidelberg OCT-A in Caucasians. The purpose of this project is to create a normative database of retinal microvascularisation using Spectralis Heidelberg optical coherence tomography angiography (OCT-A) ® in normal controls.
CONDITIONS
Official Title
Normative Database of Healthy Subject Vascular Density Using Spectralis Heidelberg® Optical Coherence Tomography Angiography
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Voluntary adult subjects or legal representative consenting for minor or subjects under protection
- Intra ocular pression 64 21mmHg
- Spherical refraction comprised between - 6 D and +6 D and/or axial length between 21 and 26mm
- Patient affiliated to social security system
You will not qualify if you...
- Ocular diseases: glaucoma, retinal diseases as diabetic retinopathy, age-related macular degeneration, amblyopia, optic neuropathy
- Diabetes mellitus
- Uncontrolled hypertension blood pressure (> 140/90)
- Recent ocular surgery (< 6 months)
- Any ophthalmological conditions interfering with a good ocular examination or OCT quality (cataract, corneal opacity 026)
- OCT-A sufficient quality 65 25 (0 = bad quality /40 = excellent quality
- Not consenting patient
- Pathological situation or handicap avoiding good installation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Amiens University Hospital
Amiens, France, 80054
Actively Recruiting
Research Team
H
Ha-Chau TRAN, Pr
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here